Related Experiment Video

Updated: Jun 18, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Late preterm infants and risk for RSV

Sherrilyn Coffman1

  • 1Nevada State College School of Nursing, Henderson, NV, USA. Sherrilyn.coffman@nsc.nevada.edu

MCN. the American Journal of Maternal Child Nursing
|November 11, 2009
PubMed

Insights

Late preterm infants are at high risk for respiratory syncytial virus (RSV) infections. This article details RSV risks, hospital care, and prevention strategies like palivizumab therapy for these vulnerable infants.

Area of Science:

  • Neonatology
  • Pediatric Infectious Diseases
  • Nursing Care

Background:

  • Late preterm infants (34-36 6/7 weeks gestation) possess physiological immaturity, increasing their susceptibility to complications.
  • Respiratory Syncytial Virus (RSV) infection poses a significant threat, often leading to hospitalization in this population.

Purpose of the Study:

  • To outline the risks and incidence of RSV infection in late preterm infants.
  • To describe comprehensive nursing care during hospitalization for RSV.
  • To detail essential hospital, home, and clinic care following discharge.

Main Methods:

  • Review of current literature on RSV infection in late preterm infants.
  • Analysis of nursing interventions for hospitalized infants.
  • Compilation of prevention strategies and clinical guidelines.

Main Results:

  • Late preterm infants face elevated risks for severe RSV outcomes.
  • Effective nursing care includes respiratory support, fluid management, and temperature regulation.
  • Palivizumab prophylaxis and adherence to clinical guidelines are crucial for prevention and management.

Conclusions:

  • Early identification and management of RSV are critical for late preterm infants.
  • A multidisciplinary approach involving healthcare providers and families ensures optimal outcomes.
  • Access to updated clinical guidelines is essential for consistent, high-quality care.

More Related Videos

Intratracheal Instillation of Stem Cells in Term Neonatal Rats04:27

Intratracheal Instillation of Stem Cells in Term Neonatal Rats

Published on: May 4, 2020

Related Concept Videos

Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: